2005
Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Dr. Giuseppe De Luca of Hospital De Weezenlanden, Zwolle, The...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has received administrative subpoenas from the United States Department of Justice U. S. Attorney's offices in Boston...
Large-Scale Pivotal Trial to Evaluate Safety and Efficacy of Next-Generation XIENCE V Coronary Stent System Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company...
Study Suggests Therapy Can Be Performed Safely by Broad Group of Physicians Indianapolis, Ind. and Washington, D.C. - Guidant Corporation (NYSE: GDT) today announced preliminary results of its...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the Federal Trade Commission (FTC) has agreed to...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today responded to statements by Johnson & Johnson on its pending acquisition...
MULTI-LINK VISION® RX Coronary Stent System Provides Thin Struts, Superb Deliverability and Excellent Clinical Results Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT) today...
High Energy System Addresses Growing Physician Demand for More Defibrillation Energy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it is informing physicians about two separate failure modes, each occurring at a low rate, being monitored within the...
Indianapolis, Ind. - Guidant announced today that the U.S. Food and Drug Administration (FDA) has completed its inspection of Guidant's Cardiac Rhythm Management facilities in St. Paul, Minnesota,...
Successful Inspection Brings Company One Step Closer to European Approval; Drug Eluting Stent Milestone Results in Payment to Novartis in Third Quarter Indianapolis, Ind. - Guidant Corporation...
Innovative Technology Directed Toward Compliance in Heart Failure Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
European Commission Ruling Necessitates Organizational and Staffing Adjustments Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that as a result of the European Commission...
Approval Sufficient for Completion of Pivotal Trial Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has received approval from the U.S. Food and Drug...
Guidant Announces Full Availability of Cardiac Rhythm Management Product Line Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...
Company Expects to Resume Implants and Distribution by Mid-week Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it received U.S. Food and Drug Administration (FDA) approval to...
Robert J. Myerburg, M.D., Internationally Recognized Leader in Electrophysiology Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Dr. Robert J. Myerburg, Professor of...
CE Mark Clears Way for Guidant to Reenter Market Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today that it received Conformité Européenne (CE) Mark approval to launch its CONTAK...
Guidant Updates Corrective Actions Regarding Its VENTAK PRIZM AVT, VITALITY AVT, and CONTAK RENEWAL AVT Implantable Cardiac Defibrillators Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said...
Worldwide implantable defibrillator revenue of $470 million, up 3 percent Worldwide coronary stent revenue of $118 million, down 2 percent Worldwide revenue from emerging businesses of $97...
District Court for Delaware Upholds Validity of Mirowski Patent Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it won a key decision in a heart failure device patent...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) said today it is voluntarily advising physicians about important safety information regarding certain devices. Guidant apprised FDA of this...
Data From Study Will Support Launch of XIENCE V Coronary Stent System Outside the United States Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE: GDT) today announced that the company...